One notable observation is that miR-133a–mediated attenuation of fibrosis occurred even without reversal of hyperglycaemia (Fig. S2), which indicates that miR-133a could also become a therapeutic target along with or without insulin for treating diabetic patients. Here, INS is linked to Hyperglycemia.